Martin Ebinger
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Hematology 23
- Hematopoietic Stem Cell Transplantation 20
- Genetics 20
- Glioma Diagnosis and Treatment 17
- Co-authors
- Rupert HandgretingerPeter LangTobias FeuchtingerMatthias PfeifferJürgen SchäferMichael SchummJörg FuchsPatrick Schlegel
- Journals
- Pediatric Blood & Cancer (8 papers)Blood (8 papers)Bone Marrow Transplantation (6 papers)Journal of Cancer Research and Clinical Oncology (4 papers)British Journal of Haematology (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Martin Ebinger
96 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 91
- Hematology 529
- Oncology 777
- Genetics 270
- Neurology 370
- Immunology 487
Countries citing papers authored by Martin Ebinger
This map shows the geographic impact of Martin Ebinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Ebinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Ebinger more than expected).
Fields of papers citing papers by Martin Ebinger
This network shows the impact of papers produced by Martin Ebinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Ebinger. The network helps show where Martin Ebinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Ebinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2020 | 3 | |
| 11 | 2019 | 6 | |
| 12 | 2019 | 208 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 20 | |
| 15 | 2016 | 17 | |
| 16 | 2016 | 15 | |
| 17 | 2013 | 12 | |
| 18 | 2013 | 2 | |
| 19 | 2011 | 23 | |
| 20 | 2004 | 5 |
About Martin Ebinger
Martin Ebinger is a scholar working on Hematology, Genetics, Neurology, Oncology and Immunology, having authored 105 papers that have together received 2.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (22 papers), Neuroblastoma Research and Treatments (22 papers), Hematopoietic Stem Cell Transplantation (20 papers), Glioma Diagnosis and Treatment (17 papers), Immune Cell Function and Interaction (15 papers), Acute Lymphoblastic Leukemia research (15 papers), Sarcoma Diagnosis and Treatment (12 papers) and Renal and related cancers (9 papers). The work is most often cited by research in Hematology (529 citations), Oncology (777 citations), Genetics (270 citations), Neurology (370 citations) and Immunology (487 citations). Martin Ebinger has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Rupert Handgretinger, Peter Lang, Tobias Feuchtinger, Matthias Pfeiffer, Jürgen Schäfer, Michael Schumm, Jörg Fuchs, Patrick Schlegel, Manon Queudeville and Heiko‐Manuel Teltschik. Their work appears in journals such as Pediatric Blood & Cancer, Blood, Bone Marrow Transplantation, Journal of Cancer Research and Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.